Monday, August 21, 2017 12:51:31 PM
Actually since IPCI said they would do those tests... then I assume that they have not been done.
What I am saying is that the FDA liaison said something like "assume" or "make believe" or "suppose" that those tests have already been done... and what it seemed to me was that she was implying that the FDA was not concerned about the Oral and Nasal tests and was interested in the panel's opinion ONLY AS FAR AS THE RESULTS OF THE IV TEST RESULTS.
Also... the application didn't just happen in a black hole... there was constant communication between IPCI and the FDA as to what was needed... and if oral and nasal tests were required for approval... why did the FDA "accept" the submission... the whole purpose of the 2 months towards acceptance is to ascertain that all the information packets required for approval are included... why would the FDA accept an incomplete application???
The possibility is there, that because most (90%???) of the abuse is through IV use... then perhaps the FDA said OK let's get it on the market with a IV ADF label ASAP since it is a superior profile... and then we will work on the other aspects.
The questions the FDA asked of the panel specifically stated, if not stressed was... suitability "in regards to intra-venous use"... WHY???
I am not implying I think the FDA is likely to grant tentative approval on September 26th... but to deny that there is any possibility is... I believe... simply... ASININE.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM